Literature DB >> 31392417

Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy.

Micah John Luderer1, Barbara Muz1, Kinan Alhallak1,2, Jennifer Sun1,2, Katherine Wasden1, Nicole Guenthner1, Pilar de la Puente1, Cinzia Federico1, Abdel Kareem Azab3,4.   

Abstract

PURPOSE: Boron neutron capture therapy (BNCT) has the potential to become a viable cancer treatment modality, but its clinical translation requires sufficient tumor boron delivery while minimizing nonspecific accumulation.
METHODS: Thermal sensitive liposomes (TSLs) were designed to have a stable drug payload at physiological temperatures but engineered to have high permeability under mild hyperthermia.
RESULTS: We found that TSLs improved the tumor-specific delivery of boronophenylalanine (BPA) and boronated 2-nitroimidazole derivative B-381 in D54 glioma cells. Uniquely, the 2-nitroimidazole moiety extended the tumor retention of boron content compared to BPA.
CONCLUSION: This is the first study to show the delivery of boronated compounds using TSLs for BNCT, and these results will provide the basis of future clinical trials using TSLs for BNCT.

Entities:  

Keywords:  boron neutron capture therapy; boronated compound; glioma; drug delivery; thermal sensitive liposomes

Mesh:

Substances:

Year:  2019        PMID: 31392417      PMCID: PMC6927330          DOI: 10.1007/s11095-019-2670-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

Authors:  Rolf D Issels; Lars H Lindner; Jaap Verweij; Peter Wust; Peter Reichardt; Baard-Christian Schem; Sultan Abdel-Rahman; Soeren Daugaard; Christoph Salat; Clemens-Martin Wendtner; Zeljko Vujaskovic; Rüdiger Wessalowski; Karl-Walter Jauch; Hans Roland Dürr; Ferdinand Ploner; Andrea Baur-Melnyk; Ulrich Mansmann; Wolfgang Hiddemann; Jean-Yves Blay; Peter Hohenberger
Journal:  Lancet Oncol       Date:  2010-04-29       Impact factor: 41.316

Review 2.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

3.  Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.

Authors:  A Tommy Bergenheim; Jacek Capala; Michael Roslin; Roger Henriksson
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

4.  Hypoxia in a human intracerebral glioma model.

Authors:  H J Bernsen; P F Rijken; H Peters; J A Raleigh; J W Jeuken; P Wesseling; A J van der Kogel
Journal:  J Neurosurg       Date:  2000-09       Impact factor: 5.115

5.  An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme.

Authors:  L Pellettieri; B H-Stenstam; A Rezaei; V Giusti; K Sköld
Journal:  Acta Neurol Scand       Date:  2008-03       Impact factor: 3.209

Review 6.  A critical assessment of boron target compounds for boron neutron capture therapy.

Authors:  M Frederick Hawthorne; Mark W Lee
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

7.  Temperature- and ionic strength-induced conformational changes in the lipid head group region of liposomes as suggested by zeta potential data.

Authors:  K Makino; T Yamada; M Kimura; T Oka; H Ohshima; T Kondo
Journal:  Biophys Chem       Date:  1991-11       Impact factor: 2.352

8.  The effect of aging on the physical stability of liposome dispersions.

Authors:  M Grit; D J Crommelin
Journal:  Chem Phys Lipids       Date:  1992-09       Impact factor: 3.329

9.  Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.

Authors:  S J Liberman; A Dagrosa; R A Jiménez Rebagliati; M R Bonomi; B M Roth; L Turjanski; S I Castiglia; S J González; P R Menéndez; R Cabrini; M J Roberti; D A Batistoni
Journal:  Appl Radiat Isot       Date:  2004-11       Impact factor: 1.513

10.  Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.

Authors:  P L Olive; R E Durand; J A Raleigh; C Luo; C Aquino-Parsons
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  7 in total

1.  Polymer-Stabilized Elemental Boron Nanoparticles for Boron Neutron Capture Therapy: Initial Irradiation Experiments.

Authors:  Alexander Zaboronok; Polina Khaptakhanova; Sergey Uspenskii; Raman Bekarevich; Ludmila Mechetina; Olga Volkova; Bryan J Mathis; Vladimir Kanygin; Eiichi Ishikawa; Anna Kasatova; Dmitrii Kasatov; Ivan Shchudlo; Tatiana Sycheva; Sergey Taskaev; Akira Matsumura
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

2.  In Vitro and In Vivo Evaluation of Fluorescently Labeled Borocaptate-Containing Liposomes.

Authors:  Vladimir Kanygin; Alexander Zaboronok; Iuliia Taskaeva; Evgenii Zavjalov; Rinat Mukhamadiyarov; Aleksandr Kichigin; Anna Kasatova; Ivan Razumov; Roman Sibirtsev; Bryan J Mathis
Journal:  J Fluoresc       Date:  2020-10-19       Impact factor: 2.217

3.  Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems.

Authors:  Hironobu Yanagie; Masashi Yanagawa; Yasuyuki Morishita; Atsuko Shinohara; Novriana Dewi; Yasumasa Nonaka; Yoshitaka Furuya; Ryouji Mizumachi; Yuuji Murata; Hiroyuki Nakamura; Minoru Suzuki; Yoshinori Sakurai; Hiroki Tanaka; Shinichiro Masunaga; Koji Ono; Takumichi Sugihara; Masayuki Nashimoto; Haruo Yamauchi; Minoru Ono; Jun Nakajima; Hiroyuki Takahashi
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

4.  Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy.

Authors:  Kinan Alhallak; Jennifer Sun; Katherine Wasden; Nicole Guenthner; Julie O'Neal; Barbara Muz; Justin King; Daniel Kohnen; Ravi Vij; Samuel Achilefu; John F DiPersio; Abdel Kareem Azab
Journal:  Leukemia       Date:  2021-01-21       Impact factor: 11.528

5.  Boron encapsulated in a liposome can be used for combinational neutron capture therapy.

Authors:  Jiyuan Li; Qi Sun; Chuanjie Lu; Han Xiao; Zhibin Guo; Dongban Duan; Zizhu Zhang; Tong Liu; Zhibo Liu
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

6.  Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.

Authors:  Cinzia Federico; Kinan Alhallak; Jennifer Sun; Kathleen Duncan; Feda Azab; Gail P Sudlow; Pilar de la Puente; Barbara Muz; Vaishali Kapoor; Luna Zhang; Fangzheng Yuan; Matea Markovic; Joseph Kotsybar; Katherine Wasden; Nicole Guenthner; Shannon Gurley; Justin King; Daniel Kohnen; Noha N Salama; Dinesh Thotala; Dennis E Hallahan; Ravi Vij; John F DiPersio; Samuel Achilefu; Abdel Kareem Azab
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 14.919

Review 7.  Boron neutron capture therapy: Current status and future perspectives.

Authors:  Mayya Alexandrovna Dymova; Sergey Yurjevich Taskaev; Vladimir Alexandrovich Richter; Elena Vladimirovna Kuligina
Journal:  Cancer Commun (Lond)       Date:  2020-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.